BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19072398)

  • 1. Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related disease.
    Pallotta S; Pace F; Marelli S
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):509-22. PubMed ID: 19072398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabeprazole for the treatment of acid-related disorders.
    Marelli S; Pace F
    Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):423-35. PubMed ID: 22928894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabeprazole: a review of its use in the management of gastric acid-related diseases in adults.
    Baldwin CM; Keam SJ
    Drugs; 2009 Jul; 69(10):1373-401. PubMed ID: 19583455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
    Devault KR
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esomeprazole: a proton pump inhibitor.
    Vachhani R; Olds G; Velanovich V
    Expert Rev Gastroenterol Hepatol; 2009 Feb; 3(1):15-27. PubMed ID: 19210109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How to choose correct proton pump inhibitors to patients with GERD?].
    Bordin DS
    Eksp Klin Gastroenterol; 2010; (2):53-8. PubMed ID: 20496811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults.
    McKeage K; Blick SK; Croxtall JD; Lyseng-Williamson KA; Keating GM
    Drugs; 2008; 68(11):1571-607. PubMed ID: 18627213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
    Bown RL
    Int J Clin Pract; 2002 Mar; 56(2):132-9. PubMed ID: 11926700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proton pump inhibitors, a family of drugs in continuous expansion].
    Pellicano R
    Minerva Gastroenterol Dietol; 2000 Dec; 46(4):231-41. PubMed ID: 19320085
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy of pantoprazole in the therapy of esophageal reflux disease].
    Lazebnik LB; Vasil'ev IuV
    Eksp Klin Gastroenterol; 2008; (2):102-4. PubMed ID: 19145874
    [No Abstract]   [Full Text] [Related]  

  • 11. Little necessity of acid inhibition against proton pump inhibitor rebound effects and prior helicobacter pylori eradication therapy in gastric ulcer patients: a randomized prospective study.
    Wada Y; Ito M; Takata S; Kitamura S; Takamura A; Tatsugami M; Imagawa S; Matsumoto Y; Tanaka S; Yoshihara M; Chayama K
    Hepatogastroenterology; 2009; 56(91-92):624-8. PubMed ID: 19621668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: efficacy and safety of rabeprazole in treating gastroesophageal reflux disease.
    Lim PW; Goh KL
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S61-8. PubMed ID: 15324384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors: the good, the bad, and the unwanted.
    Chubineh S; Birk J
    South Med J; 2012 Nov; 105(11):613-8. PubMed ID: 23128806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.
    Savarino V; Dulbecco P; de Bortoli N; Ottonello A; Savarino E
    Eur J Intern Med; 2017 Jan; 37():19-24. PubMed ID: 27784575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
    Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
    Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexlansoprazole (Kapidex) for GERD and erosive esophagitis.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):21-2. PubMed ID: 19305367
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in chirally pure proton pump inhibitors.
    Pai V; Pai N
    J Indian Med Assoc; 2007 Aug; 105(8):469-70, 472, 474. PubMed ID: 18236913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexlansoprazole in the treatment of esophagitis and gastroesophageal reflux disease.
    Abel C; Desilets AR; Willett K
    Ann Pharmacother; 2010 May; 44(5):871-7. PubMed ID: 20371754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [25 years of gastric acid blockers].
    Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharma-clinics medication of the month. Rabeprazole (Pariet)].
    Louis E
    Rev Med Liege; 2002 Jan; 57(1):53-6. PubMed ID: 11899500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.